Your browser doesn't support javascript.
loading
Pharmacokinetics of nifedipine matrix sustained-release pellets in rats and the relationship with CYP3A4 / 中国药科大学学报
Article in Zh | WPRIM | ID: wpr-811740
Responsible library: WPRO
ABSTRACT
@#To conduct the characterization of its pharmacokinetics in rats of nifedipine sustained-release pellets and to study the relationship between the pellets and CYP3A4 activity. A gradient HPLC method was developed to simultaneously determine 6β-hydroxycortisol and hydrocortisone. CYP3A4 activity of rats was quantified by urinary ratio of 6β-hydroxycortisol/hydrocortisone after intravenous injection of hydrocortisone as a biomarker. HPLC method was also developed to quantify the drug concentration in plasma of rats, and the studies of pharmacokinetics were performed after oral administration of single dose of two formulations: Nifedipine matrix sustained-release pellets and nifedipine tablet(using as control). The results showed that the ratio of ten rats was 0. 271±0. 129. cmax of nifedipine sustained-release pellets decreases by nearly 70%, tmax significantly increased by 400% and t1/2 and MRT significantly increased by 230% compared to control. Nifedipine sustained-release pellets had a significant sustained-release property compared to the control and CYP3A4 activity affected its pharmacokinetics behavior.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Journal of China Pharmaceutical University Year: 2018 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Journal of China Pharmaceutical University Year: 2018 Type: Article